Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbor Light Capital Partners is a regional venture capital firm investing primarily in early- and growth-stage technology and healthcare/life sciences businesses across New England and the Intermountain West. The fund typically invests $1–$5 million per deal with a flexible holding period focused on long-term value creation. Portfolio highlights include investments in medical device firms for neuroscience/oncology delivery platforms, regenerative biomaterials from plasma for wound healing, cannabis genomics/testing technologies for medicinal use cases, veterinary prescription management services/platforms now acquired by larger players such as KHS&S or Cray.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbor Light Capital Partners.